NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

India-EU Free Trade Agreement Update

Key Highlights

  • The European Union and India have agreed to grant each other Most-Favoured-Nation (MFN) treatment for a period of five years from the entry into force of the free trade agreement.
  • MFN treatment ensures that listed sectors, services, and service suppliers of each party are treated at least as well as those from any other country, subject to certain limits and conditions.
  • Exclusions from MFN treatment include provisions related to taxation treaties, recognition of standards or authorisations, and dispute settlement procedures.

Trade in Services Chapter

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

  • The MFN treatment was included in the Trade in Services chapter of the FTA text, which was made public on January 27.
  • A Joint Committee will review developments concerning the entry and stay of Indian students in the EU, their work rights, and arrangements for the temporary movement of service suppliers in the fourth year.

Review and Renewal

  • The Joint Committee will decide whether to continue MFN treatment beyond the initial five-year period based on the review.
  • Parties may request further review if circumstances adversely affect their interests.
  • If the Committee decides not to continue the treatment, the obligation to extend MFN treatment will cease, though benefits already granted remain unaffected.

Investor Takeaway

This trade deal may lead to increased trade and economic cooperation between India and the EU, but its impact on individual investors is unclear.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.